Study for type 2 diabetics or people who suffer from NASH
Your Diabetes Might Be Causing Liver Damage.
Non-alcoholic fatty liver disease (NASH) is the most common liver disease in developed countries. NASH is often found in people with diabetes and is associated with an increased risk of heart disease and liver cancer. At present, there are no approved medications. However, LIK066 is a novel medication being developed to treat people with NASH.
Who are we?
It takes about 12 years of research and development before a new medication is put on the market. Each medication must undergo an extensive testing process to ensure that it is both safe and effective. Humans are only involved in the very last steps of this long process, through clinical testing.
At Altasciences, we mainly conduct trials for generic formulations (copies) of medications which are already on the market, but we also conduct trials for new medications.
Participants are crucial to medical research. Without them, no new medication could be approved or improved.
Information About The Current Study
Who are we Seeking? We are seeking participants ages 18 and over who are suffering from nonalcoholic Steatohepatitis which often affects people with type 2 diabetes or people who suffer from obesity. Do you have type 2 diabetes and are not sure if you have NASH? Book an appointment at our medical center and receive at no cost a medical exam. We will be able to give you an overall health assessment and provide your values regarding your liver.
How are participants compensated for this study?For completing the clinical trial, you will be compensated up to $3,150
How long is the study?
The study includes one stay of less than 24 hours in June with several return visits.
All of the details will be explained by one of our agents over the phone.
What are the advantages of taking part in this study?
By taking part in this study, you will be helping the development of a medication type which could eventually be part of the solution to the treatment of NASH.
In addition, you will be compensated for your time.
Sign up for this study
